Terapias Avanzadas para Tumores Sólidos Pediátricos
Universidad de Salamanca
Salamanca, EspañaPublicacións en colaboración con investigadores/as de Universidad de Salamanca (6)
2023
2019
-
PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomas
Blood, Vol. 133, Núm. 22, pp. 2401-2412
2016
-
Matrix-Gla protein promotes osteosarcoma lung metastasis and associates with poor prognosis
Journal of Pathology, Vol. 239, Núm. 4, pp. 438-449
2015
-
Correlation of myelodysplastic syndromes with i(17)(q10) and TP53 and SETBP1 mutations
British Journal of Haematology
2012
-
Cortactin (CTTN) overexpression in osteosarcoma correlates with advanced stage and reduced survival
Cancer Biomarkers, Vol. 10, Núm. 1, pp. 35-41
2009
-
Profiling of chemonaive osteosarcoma and paired-normal cells identifies EBF2 as a mediator of osteoprotegerin inhibition to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis
Clinical Cancer Research, Vol. 15, Núm. 16, pp. 5082-5091